Table 3 Alternatives, attributes and levels for the DCE
From: What, who and when? Incorporating a discrete choice experiment into an economic evaluation
Defining the alternatives | Alternative Names | |
|---|---|---|
The Community Pharmacy Medicines Management Project Evaluation Team (8); Tinelli et al. (13) Medman patient survey data, analysed using Exploratory Factor Analysis (15) | - Medicines review by GP & pharmacist (GP&PH) - Medicines review by GP only (GP) - ‘Current’ situation | |
Defining the attributes/levels | Attribute name | Levels and regression coding |
Ryan et al. (11); Payne et al. (12) Medman patient survey data, analysed using Exploratory Factor Analysis (15) | ‘Advice’ [advice on medicines & health/ lifestyle] | - No advice a - Only on medicines (ADVMED) - Only on health/lifestyle (ADVHL) - On medicines & health/lifestyle (ADVMH) |
Payne et al. (12) Medman patient survey data, analysed using Exploratory Factor Analysis (15) | ‘Privacy’ in the pharmacy [consultation with your pharmacist is in a private area] | - No a - Yes (PRIVD) |
Tinelli et al. (13); Payne et al. (12) Medman patient survey data, analysed using Exploratory Factor Analysis (15) | ‘Time’ [time spent travelling to, waiting in the pharmacy] | 10 min; 20 min; 30 min; 40 min (TIME) |
Medman patient survey data, analysed using Exploratory Factor Analysis (15) | ‘Satisfactory replies’ to your questions | - No a - Yes (REPLD) |
The Community Pharmacy Medicines Management Project Evaluation Team (8); Tinelli et al. (13) | ‘Chance’ of receiving appropriate treatment | - Very poor (CH0) - Poor (CH1) - Good (CH2) - Very good a |
Ryan et al. (11); Payne et al. (12); Tinelli et al. (13) | ‘Cost’; How much you have to pay (as an indicator of value) [cost of the medicine + the cost of the medicines review and advice received + the cost of any travel] | £0; £10; £20; £30 (COST) |